Name: Tacrine
Other Names: Cognex™
Therapy Types: pharmaceutical
Mechanisms: Acetylcholinesterase inhibitor
Development Status: approved in U.S.
FDA Phase: FDA approved
Primary READ MORE http://www.alzforum.org/dis/tre/drc/detail.asp...
The first cholinesterase inhibitor approved by the FDA for treating Alzheimer's, Cognex is rarely prescribed any more, due to its known liver toxicity.